JPMorgan Chase & Co’s Intensity Therapeutics INTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15
| Closed | -$30 | – | 6399 |
|
|
2025
Q1 | $30 | Sell |
15
-2
| -12% | -$4 | ﹤0.01% | 6189 |
|
|
2024
Q4 | $30 | Hold |
17
| – | – | ﹤0.01% | 6158 |
|
|
2024
Q3 | $65 | Sell |
17
-1
| -6% | -$4 | ﹤0.01% | 6000 |
|
|
2024
Q2 | $88 | Sell |
18
-8,851
| -100% | -$43.3K | ﹤0.01% | 5888 |
|
|
2024
Q1 | $46.1K | Buy |
8,869
+8,829
| +22,073% | +$45.9K | ﹤0.01% | 5011 |
|
|
2023
Q4 | $343 | Buy |
40
+39
| +3,900% | +$334 | ﹤0.01% | 5941 |
|
|
2023
Q3 | $4 | Buy |
+1
| New | +$4 | ﹤0.01% | 6415 |
|